BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32816038)

  • 1. Targeting 14-3-3ε activates apoptotic signaling to prevent cutaneous squamous cell carcinoma.
    Holmes TR; Al Matouq J; Holmes M; Sioda N; Rudd JC; Bloom C; Nicola L; Palermo NY; Madson JG; Lovas S; Hansen LA
    Carcinogenesis; 2021 Feb; 42(2):232-242. PubMed ID: 32816038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of cytoplasmic CDC25A in cutaneous squamous cell carcinoma leads to a dependency on CDC25A for cancer cell survival and tumor growth.
    Al-Matouq J; Holmes T; Hammiller B; Tran N; Holmes M; Freeman SC; Hansen LA
    Cancer Lett; 2017 Dec; 410():41-49. PubMed ID: 28951130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting 14-3-3ε-CDC25A interactions to trigger apoptotic cell death in skin cancer.
    Holmes TR; Al-Matouq J; Holmes M; Nicola L; Rudd JC; Lovas S; Hansen LA
    Oncotarget; 2020 Sep; 11(35):3267-3278. PubMed ID: 32934772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Development of CDC25A-Derived Phosphoseryl Peptides That Bind 14-3-3ε with High Affinities.
    Kamayirese S; Maity S; Hansen LA; Lovas S
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDC25B and CDC25C overexpression in nonmelanoma skin cancer suppresses cell death.
    Al-Matouq J; Holmes TR; Hansen LA
    Mol Carcinog; 2019 Sep; 58(9):1691-1700. PubMed ID: 31237025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 Drives Inflammatory Skin Carcinogenesis Independently of C5.
    Jackson WD; Gulino A; Fossati-Jimack L; Castro Seoane R; Tian K; Best K; Köhl J; Belmonte B; Strid J; Botto M
    J Invest Dermatol; 2021 Feb; 141(2):404-414.e6. PubMed ID: 32682912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating antitumor activity of antiglypican-3 therapy in experimentally induced skin cancer in mice.
    Alyoussef A
    Arch Dermatol Res; 2021 May; 313(4):263-273. PubMed ID: 32638071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14-3-3 epsilon prevents G2/M transition of fertilized mouse eggs by binding with CDC25B.
    Cui C; Ren X; Liu D; Deng X; Qin X; Zhao X; Wang E; Yu B
    BMC Dev Biol; 2014 Jul; 14():33. PubMed ID: 25059436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing Phosphopeptide Structures That Target 14-3-3ε in Cutaneous Squamous Cell Carcinoma.
    Kamayirese S; Maity S; Dieckman LM; Hansen LA; Lovas S
    ACS Omega; 2024 Jan; 9(2):2719-2729. PubMed ID: 38250398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth.
    Ding LT; Zhao P; Yang ML; Lv GZ; Zhao TL
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1941-1948. PubMed ID: 30072096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Phosphopeptide Structures That Target 14-3-3ε in Cutaneous Squamous Cell Carcinoma.
    Kamayirese S; Maity S; Dieckman LM; Hansen LA; Lovas S
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
    Reiners JJ; Singh KP
    Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cell carcinoma cell growth in vitro and in vivo.
    Zou Y; Ge M; Wang X
    Biochem Biophys Res Commun; 2017 Aug; 490(2):385-392. PubMed ID: 28623128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
    Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
    Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Type-Specific p38δ Targeting Reveals a Context-, Stage-, and Sex-Dependent Regulation of Skin Carcinogenesis.
    Kiss A; Koppel AC; Murphy E; Sall M; Barlas M; Kissling G; Efimova T
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teriflunomide encourages cytostatic and apoptotic effects in premalignant and malignant cutaneous keratinocytes.
    Hail N; Chen P; Rower J; Bushman LR
    Apoptosis; 2010 Oct; 15(10):1234-46. PubMed ID: 20544286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of focal adhesion kinase by 14-3-3ε via NFκB activation in hepatocellular carcinoma.
    Ko BS; Jan YJ; Chang TC; Liang SM; Chen SC; Liu TA; Wu YM; Wang J; Liou JY
    Anticancer Agents Med Chem; 2013 May; 13(4):555-62. PubMed ID: 22934705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion.
    Darwiche N; Ryscavage A; Perez-Lorenzo R; Wright L; Bae DS; Hennings H; Yuspa SH; Glick AB
    Oncogene; 2007 Oct; 26(48):6885-95. PubMed ID: 17525749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.
    Scott KA; Moore RJ; Arnott CH; East N; Thompson RG; Scallon BJ; Shealy DJ; Balkwill FR
    Mol Cancer Ther; 2003 May; 2(5):445-51. PubMed ID: 12748306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.